Lumevia
Clinical Trial Training Platform

Clinical Trial Training Platform for Complex Device & Interventional Studies

Lumevia helps sponsors standardize investigator training, procedural guidance, protocol updates, and site readiness across global clinical studies.

Built for structural heart, electrophysiology, neurovascular, peripheral, surgical, and post-approval programs, Lumevia gives study teams one governed environment for study training, change control, and audit-ready oversight.

Instead of relying on scattered PDFs, email updates, disconnected portals, and uneven site adoption, sponsors can manage clinical trial training and study execution from one study-branded platform.

Investigator training
Role-based study training and readiness pathways
Procedural guidance
Videos, workflows, device instructions, and governed content
Protocol updates
Targeted amendments, acknowledgements, and version control
Learn more
Clinical trial training platform dashboard for investigators, coordinators, and sponsors
A study-branded clinical trial training platform with governed content, procedural guidance, and sponsor oversight.
Not recruitment
Does not replace patient finding tools
Not EDC
Does not replace data capture systems
Not generic LMS
Built specifically for study execution
It is the training layer
Keeps sites aligned to the right study workflow and version
What is Lumevia?

A clinical trial training platform built for study execution.

Lumevia is a clinical trial training platform designed to support investigator performance, procedural consistency, and protocol adherence in complex device and interventional clinical studies.

Unlike generic learning systems, Lumevia is built specifically for study execution. It centralizes investigator training, procedural content, governed protocol updates, and site readiness into one study-branded environment.

Sponsors use Lumevia to ensure that the right investigators receive the right training, guidance, and updates at the right time throughout the lifecycle of a study.

Study-specific training
Content organized around the study, not generic education modules.
Governed updates
Protocol changes and critical updates delivered with proof of adoption.
Procedural alignment
Training and guidance built for technique-sensitive study execution.
Sponsor visibility
Readiness, acknowledgements, and training coverage across sites.

Why device and interventional studies need a clinical trial training platform

In complex device and interventional studies, execution quality often breaks down because investigator training, procedural guidance, and protocol updates are fragmented across systems. Protocols are long, procedural content is scattered, amendments land unevenly, and site turnover resets knowledge mid-study. Sponsors often assume alignment until variability becomes visible.

Training fragmentation
Investigator training is often separated from real-world procedural workflows.
Scattered guidance
Videos, IFUs, slide decks, case content, and protocol documents live in different places.
Inconsistent updates
Amendments and new guidance do not consistently reach the right users at the right sites.
Limited readiness visibility
Clinical teams struggle to see which sites are trained and which are drifting.
No proof of adoption
Sponsors struggle to prove who saw which training, workflow, or update and when.

How Lumevia standardizes investigator training and study execution

Lumevia brings study training, procedural content, and protocol guidance into a single governed environment so sponsors can standardize site readiness, support procedural consistency, and make update adoption measurable.

01

Study-branded training hub

One environment for investigators, coordinators, field teams, and study support roles to access the training and content they actually use.

  • • Role-based training pathways
  • • Structured navigation by workflow
  • • Procedural videos, checklists, and core study materials
02

Governed protocol updates

Version control, acknowledgements, and targeted distribution so amendments and critical study changes actually land.

  • • Versioned training and guidance
  • • Update delivery by role, site, or region
  • • Expiry controls for outdated content
03

Audit-ready oversight

Visibility into investigator training, site readiness coverage, and update adoption across sites with defensible reporting.

  • • Training coverage dashboards
  • • Activity trails across users and content
  • • Exports for clinical ops and audit review

Common problems Lumevia solves

Scattered training materials
Email threads, PDFs, portals, and vendor sites become one governed study training environment.
Uneven amendment adoption
Targeted protocol updates and acknowledgements help changes land defensibly.
Limited proof of readiness
Coverage dashboards make investigator training and site readiness measurable.
Training drift over time
Lifecycle support keeps execution aligned across activation, scale-up, and post-approval phases.

How the clinical trial training platform works

Structure study content, assign access by role, publish governed training and protocol updates, and monitor readiness across the study so investigators and coordinators can find the right detail when it matters.

Step 1
Create the study training hub
Brand it to the study and organize by role, workflow, product, or region.
Step 2
Load training and procedural content
Centralize investigator training, videos, device guidance, and core study documents.
Step 3
Govern changes
Use version control, approvals, expiry rules, and targeted update delivery.
Step 4
Measure readiness
Track training coverage, acknowledgements, and update adoption by site and role.

Built to work alongside your clinical stack

Recruitment
Find patients
EDC / eSource
Capture study data
Lumevia
Standardize study training and governed execution
CTMS / Monitoring
Track performance

Why Lumevia is not a generic LMS

Traditional learning management systems focus on broad education and compliance modules. They are not designed to support procedural execution in clinical trials.

Lumevia is a clinical trial training platform built specifically for device and interventional studies, where technique consistency, governed protocol updates, and study-specific guidance directly affect study outcomes.

This distinction enables sponsors to maintain alignment between training, protocol execution, and real-world study performance.

Generic LMS
Broad learning modules, annual training, and generalized completion tracking.
Lumevia
Investigator training, procedural guidance, protocol updates, acknowledgements, and site readiness for live studies.
Use cases

Clinical trial training for complex device and interventional studies

Lumevia is a clinical trial training platform for programs where investigator readiness, procedural execution, and governed study updates directly affect study quality. Structural heart is a flagship example, but the model is broader.

Structural heart investigator training
TAVR, transcatheter, imaging-intensive and procedure-sensitive studies
Electrophysiology study training
Operator-dependent studies requiring training continuity
Neurovascular and peripheral procedure training
Technique-sensitive interventional workflows and governed updates
Post-approval and PMCF training continuity
Longer lifecycles where training intensity fades but consistency still matters

Structural heart programs as a flagship example

Structural heart studies represent some of the most execution-sensitive clinical programs. Procedural technique, imaging interpretation, and investigator experience can significantly influence study outcomes. Lumevia supports structural heart environments by enabling standardized investigator training and procedural alignment across expanding site networks.

Clinical trial training across the full study lifecycle

Training in complex studies is not a one-time event. Device and interventional programs need training infrastructure across site activation, first cases, expansion, amendments, and post-approval phases.

01
Site activation
Launch foundational training and role-based study access.
02
First procedures
Keep critical procedural guidance easy to access during early cases.
03
Scale-up
Maintain training consistency as sites and regions expand.
04
Amendments
Deliver governed training and update adoption defensibly.
05
Post-approval
Support long-term training continuity when site knowledge can decay.

Governance you can defend

A clinical trial training platform should do more than host content. It should provide controlled access, governed updates, acknowledgements, and defensible evidence of site alignment.

Role-based access
Roles, regions, and least-privilege controls
Version control
Publish, expire, and track coverage by version
Acknowledgements
Attestations for critical training and study changes
Enterprise identity
SSO / SCIM support as needed
Built on Delve Health’s clinical-grade infrastructure and operational rigor.

Audit-ready signals

Illustrative readiness signals clinical operations leaders care about.

Training coverage by role and site
Who completed what, by version
Update adoption
Which sites acknowledged which protocol changes
Activity trail
What training and guidance was accessed, when, and by whom
Exports
Evidence for internal review and audits

Training coverage, protocol updates, and site readiness

Track investigator training completion, acknowledgements, version coverage, and update adoption by site, role, region, and time.

  • • Investigator training completion by site and role
  • • Version coverage for governed study materials
  • • Amendment and update adoption trendlines
  • • Exportable evidence for clinical ops oversight

Training coverage over time

Illustrative

Replace with real metrics in your demo environment.

Clinical trial training platform FAQ

Common questions about how Lumevia supports investigator training, procedural guidance, protocol adherence, and site readiness in complex studies.

What is a clinical trial training platform?

A clinical trial training platform helps sponsors and study teams standardize investigator training, procedural guidance, study workflows, and protocol updates across sites. It is especially important in device and interventional studies where execution consistency can affect study quality.

How is Lumevia different from an LMS?

A generic LMS manages broad learning content. Lumevia is built specifically for clinical studies, helping sponsors govern training, procedural content, study updates, acknowledgements, and site readiness in one study-branded environment.

How does Lumevia support investigator training?

Lumevia supports investigator training through role-based study pathways, governed procedural content, protocol-specific guidance, and version-controlled updates that keep sites aligned throughout the study lifecycle.

Is Lumevia only for structural heart studies?

No. Structural heart is a flagship use case because it highlights the need for procedural consistency and governed training. Lumevia also supports other device and interventional categories including electrophysiology, neurovascular, peripheral, surgical, and post-approval programs.

Can Lumevia support post-approval and PMCF studies?

Yes. Lumevia is well suited for post-approval and PMCF studies where training intensity often drops over time but consistency, governed updates, and site readiness remain critical.

Does Lumevia replace an EDC, CTMS, or recruitment system?

No. Lumevia complements the clinical stack by serving as the study training and execution layer. It does not replace patient recruitment tools, data capture systems, or trial management systems.

Know your sites are aligned — not just trained

In 20 minutes you’ll see: study branding, role-based training pathways, procedural video hubs, governed protocol updates, and site readiness coverage dashboards.

Review governance
What you’ll see
  • Study-branded setup and role-based access
  • Investigator training and readiness pathways
  • Procedural video hub and governed guidance
  • Training coverage dashboards and exports
What you’ll leave with
  • Implementation plan and timeline
  • Security and governance overview
  • Sample content structure and role matrix
  • Rollout scenarios and pricing options

Lumevia — a Delve Health company. Powered by the same secure platform and infrastructure.

About Lumevia

Lumevia is developed by Delve Health, a clinical research technology company supporting global clinical programs with patient-centric and operationally rigorous solutions. Lumevia is designed as a clinical trial training platform for complex device and interventional studies where investigator readiness, procedural consistency, governed updates, and protocol adherence matter.